Yamakage, H., Tanaka, M., Inoue, T., Odori, S., Kusakabe, T., & Satoh‐Asahara, N. (2019). Effects of dapagliflozin on the serum levels of fibroblast growth factor 21 and myokines and muscle mass in Japanese patients with type 2 diabetes: A randomized, controlled trial. J Diabetes Investig.

Yamakage, Hajime, Masashi Tanaka, Takayuki Inoue, Shinji Odori, Toru Kusakabe, and Noriko Satoh‐Asahara. "Effects of Dapagliflozin On the Serum Levels of Fibroblast Growth Factor 21 and Myokines and Muscle Mass in Japanese Patients With Type 2 Diabetes: A Randomized, Controlled Trial." J Diabetes Investig 2019.

Yamakage, Hajime, et al. "Effects of Dapagliflozin On the Serum Levels of Fibroblast Growth Factor 21 and Myokines and Muscle Mass in Japanese Patients With Type 2 Diabetes: A Randomized, Controlled Trial." J Diabetes Investig 2019.